-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EDKtWwIEeNuL0bhlZ3ed01WoEADV38tG9EbcuXZSir2tAf/W30Gtl1ishJGpfFqk RsLp6xw2jixXpbRChtw4Vg== 0001179110-08-000733.txt : 20080107 0001179110-08-000733.hdr.sgml : 20080107 20080107151041 ACCESSION NUMBER: 0001179110-08-000733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080104 FILED AS OF DATE: 20080107 DATE AS OF CHANGE: 20080107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PONIARD PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000755806 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911261311 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 270 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 2062817001 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 FORMER COMPANY: FORMER CONFORMED NAME: NEORX CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRAVES FRED B CENTRAL INDEX KEY: 0001014095 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16614 FILM NUMBER: 08514873 BUSINESS ADDRESS: STREET 1: 410 WEST HARRISON ST CITY: SEATTLE STATE: WA ZIP: 98119-4007 BUSINESS PHONE: 2062817001 MAIL ADDRESS: STREET 1: 750 BATTERY ST STREET 2: STE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 4 1 edgar.xml FORM 4 - X0202 4 2008-01-04 0 0000755806 PONIARD PHARMACEUTICALS, INC. PARD 0001014095 CRAVES FRED B BAY CITY CAPITAL, LLC 750 BATTERY STREET SAN FRANCISCO CA 94111 1 0 0 0 Common Stock 2008-01-04 4 P 0 2165 4.25 A 22165 D Common Stock 2008-01-04 4 P 0 1700 4.24 A 23865 D Common Stock 2008-01-04 4 P 0 600 4.18 A 24465 D Common Stock 2008-01-04 4 P 0 300 4.17 A 24765 D Common Stock 2008-01-04 4 P 0 300 4.16 A 25065 D Common Stock 2008-01-04 4 P 0 200 4.14 A 25265 D Common Stock 2008-01-04 4 P 0 100 4.13 A 25365 D Common Stock 2008-01-04 4 P 0 100 4.15 A 25465 D Common Stock 2008-01-04 4 P 0 1787 4.21 A 27252 D Common Stock 2008-01-04 4 P 0 2207 4.23 A 29459 D Common Stock 2008-01-04 4 P 0 741 4.22 A 30200 D Common Stock 2008-01-04 4 P 0 800 4.20 A 31000 D Common Stock 2008-01-04 4 P 0 300 4.19 A 31300 D Common Stock 395791 I see footnote Common Stock 6520 I see footnote Represents the indirect interest of Dr. Craves in 4,458,481 shares of Common Stock held by Bay City Capital Fund IV, L.P. ("Fund IV"). Dr. Craves is a limited partner in Fund IV and a member of Bay City Capital Management IV, LLC ("Management IV"), the general partner of Fund IV. Dr. Craves is also a member and manager of Bay City Capital LLC ("BCC"), a member and the manager of Management IV. Dr. Craves disclaims any beneficial ownership in any of such shares. Represents the indirect interest of Dr. Craves in 96,102 shares of Common Stock held by Bay City Capital Fund IV Co-Investment Fund, L.P. ("Co-Investment IV"). Dr. Craves is a member of Management IV, the general partner of Co-Investment IV. Dr. Craves is also a member and manager of BCC, a member and the manager of Management IV. Dr. Craves disclaims any beneficial ownership in any of such shares. /s/ Fred B. Craves 2008-01-07 -----END PRIVACY-ENHANCED MESSAGE-----